Bruker (BRKR)
NASDAQHealth CareMedical - DevicesSnapshot 2026-11-04
NASDAQHealth CareMedical - DevicesSnapshot 2026-11-04
QuarterlyIQ Insights · BRKR
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | 8.7% |
| Our one-year growth estimate | diamond | 5.0% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 365 days
Most sensitive to the broad stock market.
Based on historical daily prices through 2026-11-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 3.6 percentage points more one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of 2026-11-04 · Compared with 29 industry peers · Company calendar date is not available
BRKR — dividend update
Dated 2026-10-29
Other Events. The Board of Directors of Bruker Corporation declared a quarterly cash dividend on the Company's 6.375% Mandatory Convertible Preferred Stock, Series A, $0.01 par value per share, of $3.9844 per share. The dividend was declared on October 29, 2026, and is payable December 1, 2026, to shareholders of record at the close of business on November 15, 2026. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be…
Why it matters: Q2 non-GAAP EPS rose to $0.49 from $0.32. Full-year results will test the $2.10 to $2.15 goal.
Watch forBruker keeps FY26 non-GAAP EPS guidance at $2.10 to $2.15 and reports results that support the range.
Also watch forBruker cuts FY26 non-GAAP EPS guidance below $2.10, or reports full-year EPS below $2.10.
Why it matters: Management kept its revenue range at $3.54 billion to $3.57 billion. The next report will show if results still support it.
Watch forBruker keeps FY26 revenue guidance at $3.54 billion to $3.57 billion and organic growth guidance at 1% to 2%.
Also watch forBruker cuts FY26 revenue guidance below $3.54 billion or organic growth guidance below 1%.
Why it matters: Q2 BSI bookings rose 10% and orders exceeded sales. That can support future revenue if demand holds.
Supportive ifQ3 BSI organic bookings grow year over year, and the book-to-bill ratio stays above 1.0x.
Worry ifQ3 BSI organic bookings fall year over year, or the book-to-bill ratio drops below 1.0x.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$198 on $10,000 · ±2.0% | How much price usually moves either way. |
| Bad day | $477 loss on $10,000 · 4.8% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $3,985 loss on $10,000 · 39.9% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.